MICROGYNON

This brand name is authorized in Australia, Austria, Ecuador, Hong Kong SAR China, Israel, Malta, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug MICROGYNON contains a combination of these active pharmaceutical ingredients (APIs):

1	Levonorgestrel UNII 5W7SIA7YZW - LEVONORGESTREL
	The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest.
	Read more about Levonorgestrel
2	17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL
	Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.
	Read more about 17 alpha-Ethinylestradiol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MICROGYNON Sugar-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AA07	Levonorgestrel and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1456P
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.012-03-03
ES	Centro de información online de medicamentos de la AEMPS	52612, PL00010-0545, PL00010-0545IP, PL00010-0545IP1, R-0600
GB	Medicines & Healthcare Products Regulatory Agency	30504, 30526
HK	Department of Health Drug Office	43329, 46997
IL	מִשְׂרַד הַבְּרִיאוּת	87
MT	Medicines Authority	AA770/02801
NG	Registered Drug Product Database	04-1226
Switch country to Nigeria in order to find specific presentations of MICROGYNON
NL	Z-Index G-Standaard, PRK	10383, 10502, 554525
NZ	Medicines and Medical Devices Safety Authority	2008, 2010, 2012
PL	Rejestru Produktów Leczniczych	100043816, 100441959
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64049001
SG	Health Sciences Authority	04834P
TN	Direction de la Pharmacie et du Médicament	8400011
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546120024